Medical management of endometriosis: Emerging evidence linking inflammation to disease pathophysiology

Minerva Ginecologica

Volumn 65, Issue 2, 2013, Pages 199-213

  Bruner Tran, K L ^a   Herington, J L ^a   Duleba, A J ^b   Taylor, H S ^c   Osteen, K G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometriosis; Inflammation; Progesterone resistance

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; INTERLEUKIN DERIVATIVE; MONOCYTE CHEMOTACTIC PROTEIN 1; PIOGLITAZONE; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL PROLIFERATION; CELL STRUCTURE; DISEASE COURSE; ENDOMETRIOSIS; GENE EXPRESSION; HUMAN; IMMUNOSURVEILLANCE; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FORECASTING; GENITAL DISEASES, FEMALE; GENOTYPE; HUMANS; INFLAMMATION; PROGESTERONE;

EID: 84879560877     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99. (Pubitemid 39488065)
2. Ballard K, Lowton K, Wright J. What's the delay? A qualitative study of women's experiences of reaching a diagnosis of endometriosis. Fertil Steril 2006;86:1296-301. (Pubitemid 44602075)
3. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-69.
4. Halme J, Becker S, Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am J Obstet Gynecol 1984;148:85-90. (Pubitemid 14218551)
5. Bulun SE. Endometriosis. N Engl J Med 2009:360:268-79.
6. Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci 2008;1127:106-15. (Pubitemid 351565719)
7. Montgomery GW, Nyholt DR, Zhao ZZ, Treloar SA, Painter JN, Missmer SA et al. The search for genes contributing to endometriosis risk. Hum Reprod Up-date 2008;14:447-57.
8. Bruner-Tran KL, Resuehr D, Ding T, JA L, Osteen K. The Role of Endocrine Disruptors in the Epigenetics of Reproductive Disease and Dysfunction: Potential Relevance to Humans. Current Obsteric and Gynecology Reports 2012;1:116-23.
9. Heindel JJ. Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction. Semin Reprod Med 2006;24:168-77.
10. Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG. Immune interactions in endometriosis. Expert Rev Clin Immunol 2011;7:611-26.
11. Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 2000;85:2897-902. (Pubitemid 32269170)
12. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 2002;87:4782-91. (Pubitemid 35247076)
13. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 2007;148:3814-26. (Pubitemid 47105847)
14. Khoufache K, Michaud N, Harir N, Kibangou Bondza P, Akoum A. Anomalies in the inflammatory response in endometriosis and possible consequences: a review. Minerva Endocrinol 2012;37:75-92.
15. Lebovic DI, Mwenda JM, Chai DC, Santi A, Xu X, D'Hooghe T Peroxisome proliferator-activated receptor-(gamma) receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study. Endocrinology 2010;151:1846-52.
16. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol 2003;49:285-96.
17. Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28:36-43.
18. Guo SW. The endometrial epigenome and its response to steroid hormones. Mol Cell Endocrinol 2012;358:185-96.
19. Healy DL, Hodgen GD. The endocrinology of human endometrium. Obstet Gynecol Surv 1983;38:509-30. (Pubitemid 15151188)
20. Rier SE, Yeaman GR. Immune aspects of endometriosis: relevance of the uterine mucosal immune system. Semin Reprod Endocrinol 1997;15:209-20. (Pubitemid 27500168)
21. Zhang J, Salamonsen LA. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J Clin Endocrinol Metab 2002;87:2346-51. (Pubitemid 34521529)
22. Curry TE, Jr., Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003;24:428-65. (Pubitemid 37056240)
23. Kassim SY, Gharib SA, Mecham BH, Birkland TP, Parks WC, McGuire JK. Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa. Infect Immun 2007;75:5640-50. (Pubitemid 350207800)
24. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-29. (Pubitemid 39025047)
25. Yeaman GR, Collins JE, Lang GA. Autoantibody responses to carbohydrate epitopes in endometriosis. Ann N Y Acad Sci 2002;955:174-82; discussion 99-200, 396-406.
26. Matsuzaki S, Maleysson E, Darcha C. Analysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis. Hum Reprod 2010;25:742-50.
27. Bergqvist A. Different types of extragenital endometriosis: a review. Gynecol Endocrinol 1993;7:207-21. (Pubitemid 23341602)
28. Lessey BA, Metzger DA, Haney AF, McCarty KS, Jr. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril 1989;51:409-15. (Pubitemid 19083650)
29. Li TC, Dockery P, Cooke ID. Effect of exogenous progesterone administration on the morphology of normally developing endometrium in the pre-implantation period. Hum Reprod 1991;6:641-4.
30. Al-Sabbagh M, Lam EW, Brosens JJ. Mechanisms of endometrial progesterone resistance. Mol Cell Endocrinol 2012;358:208-15.
31. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 2003;144:2870-81. (Pubitemid 36819889)
32. Igarashi TM, Bruner-Tran KL, Yeaman GR, Lessey BA, Edwards DP, Eisenberg E et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril 2005;84:67-74. (Pubitemid 40991462)
33. Nayyar T, Bruner-Tran KL, Piestrzeniewicz-Ulanska D, Osteen KG. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol 2007;23:326-36. (Pubitemid 46602923)
34. Guo SW. Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol Obstet Invest 2007;63:71-97.
35. Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kappaB: its role in health and disease. J Mol Med (Berl) 2004;82:434-48. (Pubitemid 39044283)
36. Page M, Tuckerman EM, Li TC, Laird SM. Expression of nuclear factor kappa B components in human endometrium. J Reprod Immunol 2002;54:1-13. (Pubitemid 34143090)
37. Osteen KG, Bruner-Tran KL, Eisenberg E. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril 2005;83:529-37. (Pubitemid 40348557)
38. Wu Y, Starzinski-Powitz A, Guo SW Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells. Fertil Steril 2008;90:234-7. (Pubitemid 351885197)
39. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 2006;1:106-11.
40. Bukulmez O, Hardy DB, Carr BR, Word RA, Mendelson CR. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 2008;149:1190-204. (Pubitemid 351397966)
41. Tao XJ, Tilly KI, Maravei DV, Shifren JL, Krajewski S, Reed JC et al. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. J Clin Endocrinol Metab 1997;82:2738-46. (Pubitemid 27337903)
42. Watanabe H, Kanzaki H, Narukawa S, Inoue T, Katsuragawa H, Kaneko Y et al. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol 1997;176:360-8. (Pubitemid 27107923)
43. Harada T, Kaponis A, Iwabe T, Taniguchi F, Makrydimas G, Sofikitis N et al. Apoptosis in human endometrium and endometriosis. Hum Reprod Update 2004;10:29-38. (Pubitemid 38263161)
44. Taniguchi F, Kaponis A, Izawa M, Kiyama T, Deura I, Ito M et al. Apoptosis and endometriosis. Front Biosci (Elite Ed) 2011;3:648-62.
45. Portelli M, Pollacco J, Sacco K, Schembri-Wismayer P, Calleja-Agius J. Endometrial seedlings. A survival instinct? Immunomodulation and its role in the pathophysiology of endometriosis. Minerva Ginecol 2011;63:563-70.
46. Gebel HM, Braun DP, Tambur A, Frame D, Rana N, Dmowski WP. Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil Steril 1998;69:1042-7. (Pubitemid 28274891)
47. Cakmak H, Guzeloglu-Kayisli O, Kayisli UA, Arici A. Immune-endocrine interactions in endometriosis. Front Biosci (Elite Ed) 2009;1:429-43.
48. Bruner-Tran KL, Carvalho-Macedo AC, Duleba AJ, Crispens MA, Osteen KG. Experimental endometriosis in immunocompromised mice after adoptive transfer of human leukocytes. Fertil Steril 2010;93:2519-24.
49. Wu MH, Lu CW, Chuang PC, Tsai SJ. Prostaglandin E2: the master of endometriosis? Exp Biol Med (Maywood) 2010;235:668-77.
50. Chuang PC, Lin YJ, Wu MH, Wing LY, Shoji Y, Tsai SJ. Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis. Am J Pathol 2010;176:850-60.
51. Wu MH, Shoji Y, Wu MC, Chuang PC, Lin CC, Huang MF et al. Suppression of matrix metalloproteinase-9 by prostaglandin E(2) in peritoneal macrophage is associated with severity of endometriosis. Am J Pathol 2005;167:1061-9. (Pubitemid 41416258)
52. Raiter-Tenenbaum A, Baranao RI, Etchepareborda JJ, Meresman GF, Rumi LS. Functional and phenotypic alterations in peritoneal macrophages from patients with early and advanced endometriosis. Arch Gynecol Obstet 1998;261:147-57. (Pubitemid 28301651)
53. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001;75:1-10. (Pubitemid 32041217)
54. Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 2009;175:547-56.
55. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45-51.
56. Wilson TJ, Hertzog PJ, Angus D, Munnery L, Wood EC, Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil Steril 1994;62:1086-8. (Pubitemid 24328246)
57. Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril 1993;60:834-8. (Pubitemid 23324772)
58. Semino C, Semino A, Pietra G, Mingari MC, Barocci S, Venturini PL et al. Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. Fertil Steril 1995,64:909-16.
59. Steele RW, Dmowski WP, Marmer DJ. Immunologic aspects of human endometriosis. Am J Reprod Immunol 1984;6:33-6. (Pubitemid 14063047)
60. Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y. Lymphocytes in endometriosis. Am J Reprod Immunol 2011;65:1-10.
61. Gosden R, Spears N. Programmed cell death in the reproductive system. Br Med Bull 1997;53.644-61.
62. Berbic M, Fraser IS. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol 2011;88:149-55.
63. Tariverdian N, Siedentopf F, Rucke M, Blois SM, Klapp BF, Kentenich H et al. Intraperitoneal immune cell status in infertile women with and without endometriosis. J Reprod Immunol 2009;80:80-90.
64. Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, Koga K et al. Recruitment of CCR6-expressing Th17 cells by CCL 20 secreted from IL-1 beta-, TNF-alpha-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology 2010;151:5468-76.
65. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Jr. et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995;9:2266-78.
66. Tibbetts TA, Conneely OM, O'Malley BW. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol Reprod 1999;60:1158-65. (Pubitemid 29196768)
67. Critchley HO, KeUy RW, Lea RG, Drudy TA, Jones RL, Baird DT. Sex steroid regulation of leukocyte traffic in human decidua. Hum Reprod 1996;11:2257-62. (Pubitemid 26392022)
68. Arruvito L, Giulianelli S, Flores AC, Paladino N, Barboza M, Lanari C et al. NK cells expressing a progesterone receptor are susceptible to progesterone-induced apoptosis. J Immunol 2008;180:5746-53.
69. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Sekine I, Matsuyama T et al. Estrogen and progesterone receptor expression in macrophages and regulation of hepatocyte growth factor by ovarian steroids in women with endometriosis. Hum Reprod 2005;20:2004-13. (Pubitemid 40932391)
70. Groothuis PG. What is the most appropriate phase of endometrium to use for peritoneal attachment studies? Fertil Steril 1999;72:381-2. (Pubitemid 29364648)
71. Witz CA. Cell adhesion molecules and endometriosis. Semin Reprod Med 2003;21:173-82.
72. Witz CA, Dechaud H, Montoya-Rodriguez IA, Thomas MR, Nair AS, Centonze VE et al. An in vitro model to study the pathogenesis of the early endometriosis lesion. Ann N Y Acad Sci 2002,955:296-307; discussion 40-2, 96-406.
73. Witz CA, Thomas MR, Montoya-Rodriguez IA, Nair AS, Centonze VE, Schenken RS. Short-term culture of peritoneum explants confirms attachment of endometrium to intact peritoneal mesothelium. Fertil Steril 2001;75:385-90. (Pubitemid 32112119)
74. Griffith JS, Liu YG, Tekmal RR, Binkley PA, Holden AE, Schenken RS. Menstrual endometrial cells from women with endometriosis demonstrate increased adherence to peritoneal cells and increased expression of CD44 splice variants. Fertil Steril 2010;93:1745-9.
75. Podgaec S, Dias Junior JA, Chapron C, Oliveira RM, Baracat EC, Abrao MS. Th1 and Th2 ummune responses related to pelvic endometriosis. Rev Assoc Med Bras 2010;56:92-8.
76. Zhang RJ, Wild RA, Ojago JM. Effect of tumor necrosis factor-alpha on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system. Fertil Steril 1993;59:1196-201. (Pubitemid 23163191)
77. Debrock S, De Strooper B, Vander Perre S, Hill JA, D'Hooghe TM. Tumour necrosis factor-alpha, interleukin-6 and interleukin-8 do not promote adhesion of human endometrial epithelial cells to mesothelial cells in a quantitative in vitro model. Hum Reprod 2006;21:605-9. (Pubitemid 43372962)
78. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997;99:2851-7. (Pubitemid 27278660)
79. Osteen KG, Bruner-Tran KL, Ong D, Eisenberg E. Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis. Ann N Y Acad Sci 2002;955:139-46; discussion 57-8, 396-406.
80. Ornek T, Fadiel A, Tan O, Naftolin F, Arici A. Regulation and activation of ezrin protein in endometriosis. Hum Reprod 2008;23:2104-12.
81. Bruner-Tran KL, Osteen KG, Duleba AJ. Simvastatin protects against the development of endometriosis in a nude mouse model. J Clin Endocrinol Metab 2009;94:2489-94.
82. Collette T, Bellehumeur C, Kats R, Maheux R, Mailloux J, Villeneuve M et al. Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 2004;19:1257-64. (Pubitemid 38807694)
83. Gilabert-Estelles J, Ramon LA, Espana F, Gilabert J, Castello R, Estelles A. Expression of the fibrinolytic components in endometriosis. Pathophysiol Haemost Thromb 2006;35:136-40.
84. Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 2000;294:1043-6. (Pubitemid 30666857)
85. Dje N'Guessan P, Riediger F, Vardarova K, Scharf S, Eitel J, Opitz B et al. Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. Arterioscler Thromb Vasc Biol 2009;29:380-6.
86. Shishehbor MH, Brennan ML, Aviles RJ, Fu X, Penn MS, Sprecher DL et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 2003;108:426-31. (Pubitemid 36935535)
87. Nasu K, Yuge A, Tsuno A, Narahara H. Simvastatin inhibits the proliferation and the contractility of human endometriotic stromal cells: a promising agent for the treatment of endometriosis. Fertil Steril 2009;92:2097-9.
88. Oktem M, Esinler I, Eroglu D, Haberal N, Bayraktar N, Zeyneloglu HB. High-dose atorvastatin causes regression of endometriotic implants: a rat model. Hum Reprod 2007;22:1474-80. (Pubitemid 47062821)
89. Yilmaz B, Ozat M, Kilic S, Gungor T, Aksoy Y, Lordlar N et al. Atorvastatin causes regression of endometriotic implants in a rat model. Reprod Biomed Online 2010;20:291-9.
90. Groothuis PG, Nap AW, Winterhager E, Grummer R. Vascular development in endometriosis. Angiogenesis 2005;8:147-56. (Pubitemid 41712844)
91. Nap AW, Dunselman GA, Griffioen AW, Mayo KH, Evers JL, Groothuis PG. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Fertil Steril 2005;83:793-5. (Pubitemid 40348605)
92. McLaren J, Prentice A, Charnock-Jones DS, Smith SK. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 1996;11:220-3. (Pubitemid 26047702)
93. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996;81:3112-8. (Pubitemid 26323917)
94. Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002;955:89-100; discussion 18, 396-406.
95. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003;88:2889-99. (Pubitemid 36733546)
96. Eggermont J, Donnez J, Casanas-Roux F, Scholtes H, Van Langendonckt A. Time course of pelvic endometriotic lesion revascularization in a nude mouse model. Fertil Steril 2005;84:492-9. (Pubitemid 41125275)
97. Herington JL, Crispens MA, Carvalho-Macedo AC, Camargos AF, Lebovic DI, Bruner-Tran KL et al. Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis. Fertil Steril 2011;95:1295-301 e1.
98. Herington JL, Glore DR, Lucas JA, Osteen KG, Bruner-Tran KL. Dietary fish oil supplementation inhibits formation of endometriosis-associated adhesions in a chimeric mouse model. Fertil Steril 2013 (in press).
99. Zulfikaroglu E, Kilic S, Islimye M, Aydin M, Zergeroglu S, Batioglu S. Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model. Arch Gynecol Obstet 2011;283:799-804.
100. Garcia-Velasco JA, Arici A, Zreik T, Naftolin F, Mor G. Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells: a role in endometriosis. Mol Hum Reprod 1999;5:642-50. (Pubitemid 29317754) Health and Human Development Health and Human Development Health and Human Development